Emma comes from an interdisciplinary background in Precision Medicine (PMed) device development, Neuroscience clinical research and AI Neuroimaging development. Her strengths lie in a strategic efficiency-driven mindset, combined with a curiosity and bubbly personality.
As a Precision Medicine Associate at GSK, and as part of GSK's Future Leaders Programme as a Graduate, her focus is on operationally optimising biomarker strategies across GSKs portfolio, whilst simultaneously innovating and improving processes to accelerate and standardise pipelines with a data-driven purpose.
Prior to GSK, Emma worked in Neuroscience Research in various capacities. She worked at CRO IXICO, responsible for processing large quantities clinical trial data. She worked closely with GCP and created training data for development of AI neuroimaging processing methods to improve data analysis streamlining and accuracy. She also worked on the CogThy study at the University of Gothenburg and Sahlgrenska, investigating Graves’ Disease and the hippocampus, by leading the automation process for clinical trial MRI data by integrating and comparing brain segmentation software in supercomputer processing terminals. Additionally, she undertook an independent research project in collaboration with MedTechWest where she evaluated and improved the Machine Learning neuroimaging tool Pincram.
Going back to where her interest in PMed started, at Astra Zeneca MedTech spinout company OnDosis. She was part of a dynamic start-up team and wore many hats, including heading the company’s literature research and contributing to product development of PMed dosage devices Ondosis 01, 02 and 03, where she introduced multiple new functional design aspects aiming to improve their efficiency and accuracy.
Emma holds a Bachelor of Arts and Sciences (BASc) with a Neuroscience major and Economics and Bioengineering minors from University College London (UCL). Her Bachelor’s thesis received distinction as one of the best undergraduate research dissertations in the field at UCL for an independent participant-based primary research project, where she built an sEMG-device and investigated applications for biofeedback of sonified sEMG.
Originally from Sweden, Emma grew up close to the archipelago and moved to London in 2020. She has always had a soft spot for the snow and the sea, always loving skiing and more recently discovering surfing. Emma is an active dancer, practicing with a dance crew in South London and running children’s classes to bring the joy of dance to more people. She is also passionate about women’s rights, politics and sociology, and always loves a meaningful conversation. When she is not on her feet (or skis, surfboard or skateboard), she loves thought-provoking books and spending time with her loved ones.
PANEL DISCUSSION Future of Clinical Trial Professionals: How Technology Is Transforming Workforce Roles and Expectations
Back
